Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Oyster Point Pharma, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 53 | 1 | −52 |
| Shares | 17.0M | 1 | −17.0M (−100.0%) |
| Value | $189.4M | $11 | −$189.4M (−100.0%) |
New holders (0)
Institutions that held Oyster Point Pharma, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (52)
Institutions that held Oyster Point Pharma, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.